Tech Company Financing Transactions
Bioabsorbable Therapeutics Funding Round
On 6/30/2006, Bioabsorbable Therapeutics raised funding from Synergy Life Science Partners.
Transaction Overview
Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
959 Hamilton Ave.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Not Recorded
Overview
BTI's proprietary polymers allow development of a fully bioabsorbable stent with several key advantages. The IDEAL Stent is deployed like current stents; utilizes an anti-inflammatory, therapeutic drug-delivery polymer; and permits delivery of multiple drugs with tunable release kinetics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Pat Rivelli
Chief Medical Officer
Maurice Buchbinder
VP - R & D
Alec Piplani
Browse more venture capital transactions:
Prev: 6/30/2006: Sonoma Orthopedic Products venture capital transaction
Next: 6/30/2006: Fox Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs